When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OVID - Ovid Therapeutics +9% on positive OV101 data in Fragile X Syndrome
Ovid Therapeutics Inc.
Ovid Therapeutics (NASDAQ:OVID) announces positive topline results from the signal-finding Phase 2 ROCKET trial of OV101 (gaboxadol), a novel delta (?)-selective GABAA receptor agonist, in males with Fragile X syndrome.
More news on: Ovid Therapeutics Inc., Healthcare stocks news, Stocks on the move,